ORIGINAL RESEARCH article
Front. Oncol.
Sec. Cancer Imaging and Image-directed Interventions
Volume 15 - 2025 | doi: 10.3389/fonc.2025.1637366
This article is part of the Research TopicRadiomics and AI-Driven Deep Learning for Cancer Diagnosis and TreatmentView all 11 articles
Predictive value of radiomics modelling based on dynamic and static 18 F-FDG PET/CT imaging for the differential diagnosis of lymph nodes in lung cancer
Provisionally accepted- 1National Cancer Center, Cancer Hospital Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen, China
- 2The Fourth Affiliated Hospital of Xinjiang Medical University, Xinjiang, China
- 3United Imaging Intelligence Co Ltd, Shanghai, China
- 4Tongji University Dongfang Hospital, Shanghai, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
We aimed to identify the most effective machine learning model for predicting the value of the differential diagnosis of lymph nodes (LNs) in lung cancer using dynamic and static 18 F-fluorodeoxyglucose (FDG) positron emission tomography/CT (PET/CT) imaging. Methods: A total of 279 pathologically confirmed LNs from 74 patients with lung cancer were retrospectively analyzed. It was randomly divided into a training group (N = 196) and a test group (N = 83) at a ratio of 7:3. Radiomics features of the images were extracted from CT, dynamic PET (dPET) and static PET (PET) images and were screened for the most predictive value. Build Support Vector Machine (SVM), Logistic Regression (LR) and Random Forest (RF) machine learning models were build using the optimal radiomics features. The best quantitative prediction model was suggested using SUVmax and Ki based on LNs. A composite model was build based on the best machine learning model and quantitative models. Receiver operating characteristic (ROC) curves were used to evaluate the predictive ability of the machine learning, quantitative and composite models to predict LNs metastasis in lung cancer. Results: Of the three machine learning models, the RF model demonstrated the greatest predictive efficacy in both the training (AUC of 0.823) and test (AUC of 0.819) groups. The quantitative model based on Ki showed good predictive efficacy in both the training (AUC of 0.772) and test groups (AUC of 0.805) groups. A composite model based on both the RF machine learning model and the quantitative model demonstrated superior predictive efficacy. The respective AUCs in the training and test groups were 0.844 and 0.835, respectively. Decision curve analysis has shown that the composite model has better net benefit and clinical value. Conclusion: A composite model based on an RF model of PET/CT+Ki images, combined with dynamic quantitative Ki, is highly effective in differentiating FDG-avid LN metastasis in lung cancer. This model provides greater net benefit and clinical value.
Keywords: lung cancer, 18 F-FDG, PET/CT, dynamic, Radiomics model
Received: 29 May 2025; Accepted: 18 Aug 2025.
Copyright: © 2025 Wumener, Hu, Zhao, Wang, Zhang, Deng, Zhao and Liang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Xieraili Wumener, National Cancer Center, Cancer Hospital Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.